Search

Prince Akwasi Mensah

Examiner (ID: 16550, Phone: (571)270-7183 , Office: P/2474 )

Most Active Art Unit
2474
Art Unit(s)
2416, 2474
Total Applications
590
Issued Applications
431
Pending Applications
63
Abandoned Applications
119

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5057699 [patent_doc_number] => 20070060621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Methods and compositions for the administration of prodrugs of proton pump inhibitors' [patent_app_type] => utility [patent_app_number] => 10/554151 [patent_app_country] => US [patent_app_date] => 2005-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6171 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060621.pdf [firstpage_image] =>[orig_patent_app_number] => 10554151 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/554151
Methods and compositions for the administration of prodrugs of proton pump inhibitors Jan 12, 2005 Abandoned
Array ( [id] => 680369 [patent_doc_number] => 07084174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Administration of isovaleryl L-carnitine to stimulate osteoblastic activity' [patent_app_type] => utility [patent_app_number] => 11/032019 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1918 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084174.pdf [firstpage_image] =>[orig_patent_app_number] => 11032019 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/032019
Administration of isovaleryl L-carnitine to stimulate osteoblastic activity Jan 10, 2005 Issued
Array ( [id] => 7040646 [patent_doc_number] => 20050159453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Novel methods for the treatment and prevention of ileus' [patent_app_type] => utility [patent_app_number] => 11/024097 [patent_app_country] => US [patent_app_date] => 2004-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14225 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159453.pdf [firstpage_image] =>[orig_patent_app_number] => 11024097 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/024097
Novel methods for the treatment and prevention of ileus Dec 27, 2004 Abandoned
Array ( [id] => 6906176 [patent_doc_number] => 20050101571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Methods of treating cancer using a combination of drugs' [patent_app_type] => utility [patent_app_number] => 11/012621 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5800 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101571.pdf [firstpage_image] =>[orig_patent_app_number] => 11012621 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/012621
Methods of treating cancer using a combination of drugs Dec 15, 2004 Abandoned
Array ( [id] => 5029048 [patent_doc_number] => 20070270495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Use of Cystine or Cysteine for the Prevention and Treatment of Oxidative Stress Cause by Haemodialysis and of Acute or Chronic Kidney Diseases' [patent_app_type] => utility [patent_app_number] => 10/583334 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1160 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270495.pdf [firstpage_image] =>[orig_patent_app_number] => 10583334 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/583334
Method for treating hemodialysis-related oxidative stress using cystine or cysteine Dec 15, 2004 Issued
Array ( [id] => 6906148 [patent_doc_number] => 20050101543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Treatments for neurogenetic disorders, impulse control disorders, and wound healing' [patent_app_type] => utility [patent_app_number] => 11/013259 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10273 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101543.pdf [firstpage_image] =>[orig_patent_app_number] => 11013259 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/013259
Treatments for neurogenetic disorders, impulse control disorders, and wound healing Dec 14, 2004 Abandoned
Array ( [id] => 4989500 [patent_doc_number] => 20070155841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Preventive agent for carcinogenesis of liver cancer containing quinone-based compound as active ingredient' [patent_app_type] => utility [patent_app_number] => 10/596945 [patent_app_country] => US [patent_app_date] => 2004-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2400 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155841.pdf [firstpage_image] =>[orig_patent_app_number] => 10596945 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/596945
Preventive agent for carcinogenesis of liver cancer containing quinone-based compound as active ingredient Dec 13, 2004 Abandoned
Array ( [id] => 7145827 [patent_doc_number] => 20050119297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Use of 5HT3 agonists for relaxing the fundus' [patent_app_type] => utility [patent_app_number] => 11/010590 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1311 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119297.pdf [firstpage_image] =>[orig_patent_app_number] => 11010590 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/010590
Use of 5HT3 agonists for relaxing the fundus Dec 12, 2004 Abandoned
Array ( [id] => 5005591 [patent_doc_number] => 20070203163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Novel Treatment Of Irritable Bowel Syndrome 1' [patent_app_type] => utility [patent_app_number] => 10/582388 [patent_app_country] => US [patent_app_date] => 2004-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1973 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203163.pdf [firstpage_image] =>[orig_patent_app_number] => 10582388 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582388
Novel Treatment Of Irritable Bowel Syndrome 1 Dec 7, 2004 Abandoned
Array ( [id] => 5080327 [patent_doc_number] => 20070123551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Use of metabotropic glutamarate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders' [patent_app_type] => utility [patent_app_number] => 10/582182 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2240 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123551.pdf [firstpage_image] =>[orig_patent_app_number] => 10582182 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582182
Use of metabotropic glutamarate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders Dec 6, 2004 Abandoned
Array ( [id] => 7173302 [patent_doc_number] => 20050203163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/004635 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8327 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203163.pdf [firstpage_image] =>[orig_patent_app_number] => 11004635 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/004635
Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the treatment of cancer Dec 2, 2004 Abandoned
Array ( [id] => 7075362 [patent_doc_number] => 20050148630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Methods of preventing and treating non-opioid induced gastrointestinal dysfunction' [patent_app_type] => utility [patent_app_number] => 10/998793 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14063 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148630.pdf [firstpage_image] =>[orig_patent_app_number] => 10998793 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/998793
Methods of preventing and treating non-opioid induced gastrointestinal dysfunction Nov 28, 2004 Abandoned
Array ( [id] => 7105166 [patent_doc_number] => 20050107346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activity' [patent_app_type] => utility [patent_app_number] => 10/994639 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11427 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107346.pdf [firstpage_image] =>[orig_patent_app_number] => 10994639 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/994639
N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activity Nov 22, 2004 Abandoned
Array ( [id] => 5819925 [patent_doc_number] => 20060024238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Compositions and methods using proton pump inhibitors' [patent_app_type] => utility [patent_app_number] => 10/988586 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11830 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024238.pdf [firstpage_image] =>[orig_patent_app_number] => 10988586 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/988586
Compositions and methods using proton pump inhibitors Nov 15, 2004 Abandoned
Array ( [id] => 7163747 [patent_doc_number] => 20050085551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Bupropion to treat viral diseases' [patent_app_type] => utility [patent_app_number] => 10/980282 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3177 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085551.pdf [firstpage_image] =>[orig_patent_app_number] => 10980282 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/980282
Bupropion to treat viral diseases Nov 3, 2004 Abandoned
Array ( [id] => 5023538 [patent_doc_number] => 20070149504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Use of neurokinin antagonists in the treatment of urinary incontinence' [patent_app_type] => utility [patent_app_number] => 10/576052 [patent_app_country] => US [patent_app_date] => 2004-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3559 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149504.pdf [firstpage_image] =>[orig_patent_app_number] => 10576052 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/576052
Use of neurokinin antagonists in the treatment of urinary incontinence Oct 25, 2004 Issued
Array ( [id] => 6991494 [patent_doc_number] => 20050090531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'MAG expression promoters' [patent_app_type] => utility [patent_app_number] => 10/969885 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7057 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090531.pdf [firstpage_image] =>[orig_patent_app_number] => 10969885 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/969885
MAG expression promoters Oct 21, 2004 Issued
Array ( [id] => 6918771 [patent_doc_number] => 20050096332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Use of tyrosine kinase inhibitors for the treatment of inflammatory processes' [patent_app_type] => utility [patent_app_number] => 10/967396 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3294 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096332.pdf [firstpage_image] =>[orig_patent_app_number] => 10967396 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/967396
Use of tyrosine kinase inhibitors for the treatment of inflammatory processes Oct 17, 2004 Abandoned
Array ( [id] => 7117201 [patent_doc_number] => 20050070502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Composition and method for the treatment of dysglucaemia' [patent_app_type] => utility [patent_app_number] => 10/953453 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6994 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070502.pdf [firstpage_image] =>[orig_patent_app_number] => 10953453 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/953453
Composition and method for the treatment of dysglucaemia Sep 29, 2004 Abandoned
Array ( [id] => 7117302 [patent_doc_number] => 20050070603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Use of glycerides to alleviate symptoms of digestive disorders' [patent_app_type] => utility [patent_app_number] => 10/951204 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1328 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070603.pdf [firstpage_image] =>[orig_patent_app_number] => 10951204 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/951204
Use of glycerides to alleviate symptoms of digestive disorders Sep 26, 2004 Abandoned
Menu